Track 1:Cellular and Molecular Genetics

The study of genetics at the level of the basic building blocks of cells and at the DNA level. Cells are as complex as they are tiny and much is still unknown about the inner workings of these building blocks of life. If you'd like to log hours in a lab and use advanced equipment to help advance the understanding of how cells work, studies in cellular and molecular biology could be for you. Biology is the study of living things, and cellular or molecular biology studies living things on the smallest possible scale. To prepare for a career in cellular or molecular biology, individuals must have a strong understanding of chemistry, statistics and physics. The research of cellular and molecular biologists is integral to things like the development of new medications, the protection of aquatic ecosystems and the improvement of agricultural products. A student pursuing an undergraduate or graduate degree in cellular and molecular Genetics spends time divided between classroom lectures and practical laboratory instruction. Research is an important part of this field, and students must be comfortable using highly advanced pieces of equipment to conduct experiments. In addition, cellular and molecular biology programs teach students about cellular structures and their functions, how cells make and use things like proteins and enzymes and much more. Courses covered in a molecular or cellular biology degree program may include microbiology, epidemiology, microscopy and molecular genetics. The following Study.com articles offer more details about this field of study.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

International Conference on Clinical AndMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31October 02November 2016 (Valencia, Spain); International Conference on Genetic Counselling AndGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); 2015 Midwest Conference onCell Therapy& Regenerative Medicine September 18-19 2015 (Kansas City, Missouri); 2nd Cell &Gene TherapyConference 9-10 September 2015 (Philadelphia, United States); Cell &Gene TherapyEurope 29-30 September 2015 (Barcelona, Spain); Cell Manufacturing andGene TherapyCongress 2015 2-3 December 2015 (Brussels, Belgium).

Track 2:Clinical Genetics

Clinical Genetics is the medical specialty which provides a diagnostic service and "genetic counselling" for individuals or families with, or at risk of, conditions which may have a genetic basis. Genetic disorders can affect any body system and any age group. The aim of Genetic Services is to help those affected by, or at risk of, a genetic disorder to live and reproduce as normally as possible. In addition a large number of individuals with birth defects and/or learning disabilities are referred and investigated for genetic factors. Individuals identified through childhood or pregnancy screening programmes also require genetic services. In the future, as the genetic contributions to common later-onset disorders such as diabetes and coronary heart disease are identified, genetic services may be required for those at high risk. Testing for genetic factors that affect drug prescribing will also increasingly become an important activity.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); International Conference on Genetic Counselling AndGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 3:Genomics: Disease & Evolution

Genomicsis a discipline ingeneticsthat appliesrecombinant DNA,DNA sequencingmethods, andbioinformaticsto sequence, assemble, and analyze the function and structure ofgenomes(thecompleteset of DNA within a single cell of an organism).Advances in genomics have triggered a revolution in discovery-based research to understand even the most complex biological systems such as the brain.The field includes efforts to determine the entireDNA sequenceof organisms and fine-scalegenetic mapping. The field also includes studies of intragenomic phenomena such asheterosis,epistasis,pleiotropyand other interactions betweenlociandalleleswithin the genome.In contrast, the investigation of the roles and functions of single genes is a primary focus ofmolecular biologyorgeneticsand is a common topic of modern medical and biological research. Research of single genes does not fall into the definition of genomics unless the aim of this genetic, pathway, and functional information analysis is to elucidate its effect on, place in, and response to the entire genome's networks.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

Cell &Gene TherapyCongress, 19-21 May 2016 (San Antonio, USA); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); 2nd International Congress on Neuroimmunology and Therapeutics, March 31-April 02, 2016 (Atlanta, USA); 2nd International Conference and Exhibition on Antibodies, July 14-15, 2016 (Philadelphia, USA); 16th International Congress of Immunology, August 21-26, 2016 (Melbourne, Australia); IMMUNOLOGY 2016, AAI Annual Meeting, May 1317, 2016 (Seattle, WA); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 4: Cancer Genetics:

Canceris agenetic disorderin which the normal control ofcell growthis lost.Cancer geneticsis now one of the fastest expandingmedical specialties. At themolecularlevel, cancer is caused bymutation(s)inDNA, which result in aberrantcellproliferation. Most of these mutations areacquiredand occur insomatic cells. However, some peopleinherit mutation(s) in thegerm line. The mutation(s) occur in two classes of cellulargenes:oncogenesandtumor suppressor genes. Under normal conditions, tumor suppressor genes regulate cellular differentiation and suppression of proliferation. Mutations in these genes result in unchecked cellular proliferation resulting in tumors with abnormalcell cyclesand tumor proliferation. The tumor suppressor genes contribute to cancer by the inactivating ofloss of function mutation.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

International Conference onCervical Cancer,22-23 September, 2016 (Vienna, Austria); 6th World Congress onCancer Therapy, 01-03 December, 2016 (Baltimore, USA); 13th Global Summit onCancer Therapy17-19 October, 2016 (Dubai, UAE); International Conference onPancreaticand Colorectal Cancer, 29-30 March, 2016 (Atlanta, USA); Global Summit onMelanomaAnd Carcinoma, 14-15 July, 2016 (Brisbane, Australia); Chromatin andEpigeneticin Cancer ( Atlanta, Georgia); Advances inOvarianCancer Research: Exploiting Vulnerabilities (Orlando, Florida); Advance inBreast CancerResearch ( Washington, DC); Advances inPediatric CancerResearch (Florida); New Horizons in Cancer Research Conference (Sanghai, China).

Track 5:Stem cells and Regenerative Medicine

Many of the stem cells being studied are referred to aspluripotent, meaning they can give rise to any of the cell types in the body but they cannot give rise on their own to an entirely new body. (Only the earliest embryonic cells, which occur just after fertilization, can give rise to a whole other organism by themselves.) Other stem cells, such as the ones found in the adult body, aremultipotent, meaning they can develop into a limited number of different tissue types. One of the most common stem cell treatments being studied is a procedure that extracts a few stem cells from a person's body and grows them in large quantities in the laboratorywhat scientists refer to as expanding the number of stem cells. Once a sufficient number have been produced in this manner, the investigators inject them back into the patient. You could say that medicine up until now has been all about replacements. If your heart valve isn't working, you replace it with another valve, say from a pig. With regenerative medicine, you're treating the cause and using your own cells to perform the replacement. The hope is that by regenerating the tissue, you're causing the repairs to grow so that it's like normal.

Genetic disorders may or may not be heritable, i.e., passed down from the parents' genes. In non-heritable genetic disorders, defects may be caused by new mutations or changes to the DNA

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); International Conference on Genetic Counselling AndGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 6:Cancer and Genome Integrity

The research program in the Genome Integrity is focused on the exploration of the causes and effects of genomic instability, mechanisms of DNA repair and the study of DNA repair breakdown as an initiating or protective event in aging and cancers. The program will emphasize a mechanistic understanding of the pathways that maintain genomic integrity, the intersection of these pathways with normal cellular physiology and cancer and the application of these insights to the development of new therapeutic strategies.The Genome integrity has made major contributions towards a detailed understanding of DNA repair pathway selection as a primary influence on genomic stability and drug resistance/sensitivity in breast and ovarian cancers and the influential role of DNA repair proteins in the promotion of specific hematological malignancies

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 7:Diabetes and Obesity

The UK is officially the 'fattest' country in Europe, with approximately1 in 5adults overweight and one in every 15 obese. Over the next 20 years, the number of obese adults in the country is forecast to soar by a staggering 73% to 26 million people. According to health experts, such a rise would result in more than a million extra cases oftype 2 diabetes,heart diseaseandcancer. Obesity is also no longer a condition that just affects older people, although the likelihood does increase with age, and increasing numbers of young people have been diagnosed with obesity. While the exact causes of diabetes are still not fully understood, it is known that factors up the risk of developing different types of diabetes mellitus.For type 2 diabetes, this includes being overweight or obese (having a body mass index - BMI - of 30 or greater).In fact, obesity is believed to account for 80-85% of the risk of developing type 2 diabetes, while recent research suggests that obese people are up to 80 times more likely to develop type 2 diabetes than those with aBMI of less than 22.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track 8:Congenital disorders

Congenital disorder, also known ascongenital disease,birth defectoranomaly is a condition existing at or beforebirth regardless of cause. Of these diseases, those characterized by structural deformities are termed "congenital anomalies" and involve defects in a developingfetus. Birth defects vary widely in cause and symptoms. Any substance that causes birth defects is known as ateratogen. Some disorders can be detected before birth throughprenatal diagnosis(screening). Birth defects are present in about 3% of newborns in USA.Congenital anomalies resulted in about 632,000 deaths per year in 2013 down from 751,000 in 1990.[9]The type with the greatest numbers of deaths arecongenital heart disease(323,000), followed byneural tube defects(69,000).

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

4th International Conference on Integrative Biology, July 18-20, 2016 (Berlin, Germany); International Conference on Genetic Counseling and Genomic Medicine, August 11-12, 2016 (Birmingham, UK); International Conference on Synthetic Biology, August 15-17, 2016 (London, United Kingdom); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); World Congress onHuman Genetics, 31 October02 November 2016 (Valencia, Spain); Mitochondrial Dynamics (D2), April 3-7, 2016 (Colorado, USA); Mitochondrial Medicine 2016, June 15-18, 2016 (Seattle,USA); The 2016 Gordon Research Conference on Mitochondria & Chloroplasts, June 19-24, 2016 (Vermont, USA); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 9:Cytogenetics

Cytogeneticsis a branch ofgeneticsthat is concerned with the study of the structure and function of the cell, especially the chromosomes. It includes routine analysis ofG-bandedchromosomes, other cytogenetic banding techniques, as well asmolecular cytogeneticssuch asfluorescentin situhybridization(FISH) andcomparative genomic hybridization(CGH). Chromosomes were first observed in plant cells byKarl Wilhelm von Ngeliin 1842. Their behavior in animal (salamander) cells was described byWalther Flemming, the discoverer ofmitosis, in 1882. The name was coined by another German anatomist,von Waldeyerin 1888.

The next stage took place after the development of genetics in the early 20th century, when it was appreciated that the set of chromosomes (thekaryotype) was the carrier of the genes. Levitsky seems to have been the first to define the karyotype as thephenotypicappearance of thesomaticchromosomes, in contrast to theirgeniccontents. Investigation into the human karyotype took many years to settle the most basic question: how many chromosomes does a normaldiploidhuman cell contain? In 1912,Hans von Winiwarterreported 47 chromosomes inspermatogoniaand 48 inoogonia, concluding anXX/XOsex determinationmechanism. Painterin 1922 was not certain whether the diploid number of man was 46 or 48, at first favoring 46.He revised his opinion later from 46 to 48, and he correctly insisted on man having anXX/XYsystem. Considering their techniques, these results were quite remarkable.

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track 10:Transplantation

Transplantation is the transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function(s) in the body. When transplantation is performed between different species, e.g. animal to human, it is named xenotransplantation. Development of the field of organ and tissue transplantation has accelerated remarkably since the human major histocompatibility complex (MHC) was discovered in 1967. Matching of donor and recipient for MHC antigens has been shown to have a significant positive effect on graft acceptance. The roles of the different components of the immune system involved in the tolerance or rejection of grafts and in graft-versus-host disease have been clarified. These components include: antibodies, antigen presenting cells, helper and cytotoxic T cell subsets, immune cell surface molecules, signaling mechanisms and cytokines that they release. The development of pharmacologic and biological agents that interfere with the alloimmune response and graft rejection has had a crucial role in the success of organ transplantation Combinations of these agents work synergistically, leading to lower doses of immunosuppressive drugs and reduced toxicity. Reports of significant numbers of successful solid organ transplants include those of the kidneys, liver, heart and lung. The use of bone marrow transplantation for hematological diseases, particularly hematological malignancies and primary immunodeficiencies, has become the treatment of choice in many of these conditions

Related Genetics Conferences | Human Genetics Conferences | Conference Series LLC

World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic & Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia)

Track 11:Neurodevelopmental disorders

Neurodevelopmental disordersare impairments of the growth and development of the brain orcentral nervous system. A narrower use of the term refers to a disorder of brain functionthat affectsemotion,learning ability,self-controlandmemoryand that unfolds as the individualgrows. The term is sometimes erroneously used as an exclusive synonym forautismandautism spectrumdisorders. The development of the brain is orchestrated, tightly regulated, and genetically encoded process with clear influence from the environment. This suggests that any deviation from this program early in life can result in neurodevelopmental disorders and, depending on specific timing, might lead to distinct pathology later in life. Because of that, there are many causes of neurodevelopmental disorder, which can range from deprivation,geneticandmetabolic diseases, immune disorders,infectious diseases,nutritionalfactors, physical trauma, and toxic and environmental factors. Some neurodevelopmental disorderssuch asautismand otherpervasive developmental disordersare considered multifactorialsyndromes(with many causes but more specific neurodevelopmental manifestation).

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track12:Pharmacogenetics

Pharmacogeneticsis the study of inheritedgeneticdifferences in drugmetabolic pathwayswhich can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects.The term pharmacogenetics is often used interchangeably with the termpharmacogenomicswhich also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behavior through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function. In oncology,pharmacogeneticshistorically is the study ofgerm line mutations(e.g.,single-nucleotide polymorphismsaffecting genes coding for liver enzymes responsible for drug deposition andpharmacokinetics), whereaspharmacogenomicsrefers tosomatic mutationsintumoralDNA leading to alteration in drug response (e.g.,KRASmutations in patients treated withanti-Her1biologics).

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track13:Pharmacogenomics

Pharmacogenomics is the study of how genes affect a persons response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a persons genetic makeup. Many drugs that are currently available are one size fits all, but they dont work the same way for everyone. It can be difficult to predict who will benefit from a medication, who will not respond at all, and who will experience negative side effects (called adverse drug reactions). Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. With the knowledge gained from the Human Genome Project, researchers are learning how inherited differences in genes affect the bodys response to medications. These genetic differences will be used to predict whether a medication will be effective for a particular person and to help prevent adverse drug reactions.The field of pharmacogenomics is still in its infancy. Its use is currently quite limited, but new approaches are under study in clinical trials. In the future, pharmacogenomics will allow the development of tailored drugs to treat a wide range of health problems, including cardiovascular disease,Alzheimer disease, cancer, HIV/AIDS, and asthma.

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track14:Drug discovery

Driven by chemistry but increasingly guided by pharmacology and the clinical sciences,drugresearch has contributed more to the progress of medicine during the past century than any other scientific factor. Improving the science ofdrug developmentand regulation is important in fulfilling the public health. The advent of molecular biology and, in particular, of genomic sciences is having a deep impact ondrug discovery. Emphasis is placed on the contrast between the academic and industrial research operating environments, which can influence the effectiveness of research collaboration between the two constituencies, but which plays such an important role indrug innovation. The strategic challenges that research directors face are also emphasized.

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track15:Bioinformatics in Human Genetics

Recent developments, including next-generation sequencing (NGS), bio-ontologies and the Semantic Web, and the growing role of hospital information technology (IT) systems and electronic health records, amass ever-increasing amounts of data before human genetics scientists and clinicians. However, they have ever-improving tools to analyze those data for research and clinical care. Correspondingly, the field of bioinformatics is turning to research questions in the field of human genetics, and the field of human genetics is making greater use of bioinformatic algorithms and tools. The choice of "Bioinformatics and Human Genetics" as the topic of this special issue of Human Mutation reflects this new importance of bioinformatics and medical informatics in human genetics. Experts from among the attendees of the Paris 2010 Human Variome Project symposium provide a survey of some of the "hot" computational topics over the next decade. These experts identify the promise-what human geneticists who are not themselves bioinformaticians stand to gain-as well as the challenges and unmet needs that are likely to represent fruitful areas of research.

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

Track16:Anthropology

Anthropologyis the study ofhumanity.Its main subdivisions aresocialandcultural anthropology, which describes the workings of societies around the world,linguistic anthropology, which investigates the influence of language in social life, and biological or physical anthropology. Anthropology concerns long-term development of the human organism.Archaeology, which studies past human cultures through investigation of physical evidence, is thought of as a branch of anthropology in the United States, although in Europe, it is viewed as a discipline in its own right, or grouped under related disciplines such as history.

RelatedGenetics Conferences|Human Genetics Conferences|Conference Series LLC

International Conference on Clinical andMolecular Genetics, 28-30 November 2016 (Chicago, USA); 6thInternational Conference on Genomics &Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress onHuman Genetics, 31 October 02 November 2016 (Valencia, Spain); International Conference on Genetic Counselling andGenomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell &Gene TherapyCongress, 19-21 May 2016 ( San Antonio, USA); Game ofEpigenomicsConference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial AmericanCytogeneticsConference,16-18 May, 2016 (Oregon, USA); The EuropeanHuman GeneticsConference 2016, 21-24 May, 2016 (Barcelona, Spain); 4thInternational workshop onCancer Genetic&CytogeneticDiagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin andEpigenetics, 20-24 Mar 2016 (Whistler, Canada)

1. Scope and Importance of Human Genetics:

Scope: The Scope of the conference is to gather all the Doctors, Researchers, Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere. This Human Genetics Conference is the premier event focusing on understanding individual and organizational behaviour and decision-making related to genetics and molecular biology, biotechnology, pharmaceuticals, medicals and academia.

Importance: Conference on Human Genetics is a much celebrated conference which basically deals with the latest research and developments in the sphere of genetics and molecular biology. This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with Ph.D. Students to come and inform all the attendees about the latest scientific advancements on the respective sphere.

2. Why its in Valencia, Spain?

In the last decade, pre-implantation genetic diagnosis and screening (PGD; PGS) have become widely used in IVF treatments: in 2005 nearly 6000 PGD/PGS (5 per cent of all IVF cycles) had been performed in Europe. The diffusion of these technologies, however, is not homogenous; whilst in some countries PGD is prohibited and in others is hardly implemented, Spain performs 33 per cent of all the PGD/PGS (ESHRE 2007). Combining the analysis of juridical documents with semi-structured interviews to past and present members of the Spanish National Assisted Reproduction Committee (CNRHA), this study suggests that the remarkable diffusion of PGD/PGS in Spain may be largely due to the interaction between the growing momentum enjoyed by embryonic stem cell research and a vibrant expansion of IVF business along the Mediterranean coast. In this process, genetic issues per se seem to play a minor role, although the prevention of genetic diseases constitutes the formal rationale for the extension of PGD from monogenic, early onset diseases to polygenic, late-onset ones.

3. Member Associated with Human Genetics Research

The Members who are associated with Genetics Research includes Societies, Associations, Institutes, Universities and other Research Organizations.

A. City Statistics: Approximately, more than 2876 members involved in Genetics and related researches in the city of Valencia.

B. Country Statistics: Approximately, more than 17775 members involved in Genetics and related researches in Spain.

C. Worldwide statistics: Europe: Approximately, more than 56083 members involved in Genetics and related researches. USA: Approximately, more than 24285 members involved in Genetics and related researches. Global: Approximately, 1291100 members involved in Genetics and related researches.

4. Societies Associated with Human Genetics Research

Some of the renowned societies involved in genetic research

A. Societies in Valencia and Spain:

B. Societies in Europe:

C. Societies in Globe:

5. Industries Associated with Human Genetics Research:

The Major Industries or Companies and laboratories associated with Genetics research are listed below:

A. By City - Some of the major companies in Valencia:

Sistemas Genomicos, Reproductive Genetics Unit, Paterna (Valencia); Instituto de Medicina Genmica, IMEGEN, Paterna (Valencia); LifeSequencing; Oncovision etc.

B. By Country Some of the major companies in Spain:

AC-Gen Reading Life SL, Valladolid; Cidegen, SL, Salamanca; Diagnostico Genetico Canarias, Las Palmas de Gran Canaria; Genetadi Biotech, GENETADI, Derio-BILBAO (SPAIN); GENETAQ, Molecular Genetics Centre, Malaga; Genetracer Biotech, Santander; Genyca, Madrid; Health in Code S.L., Corua; Innovagenomics S.L, Innovagenomics, Salamanca; Diagnostics in Iron Metabolism Diseases (DIRON), Badalona

C. Global:

Abbott Laboratories; AutoGenomics; Biocartis; Bio-Rad Laboratories; Cepheid; EKF Diagnostics; Elitech Group; IntegraGen; Interpace Diagnostics; Myriad Genetics; Perkin Elmer; Qiagen; Quest Diagnostics; Roche Diagnostics; WaferGen Biosystems

6. Universities Associated with Human Genetics

A. City Statistics:

University of Valencia , Universidad catolica de Valencia, Valencian international university, CEU Cardenal Herrera University, La Universidad Catlica de Valencia

B. Country Statistics - Spain:

University of Zaragosa, University of Barcelona, Universitat Pompeu Fabra, Universidad Complutense de Madrid , Universidad Autonoma de Madrid

C. Worldwide Statistics:

European university Switzerland, Vilnius university, Uppsala University, Universita degli study di Torino, Maastricht University, Graz University of Technology, Harvard University, Leiden University Medical Center, Center for Human and Clinical Genetics, University of Oxford, Stanford University, University of Cambridge.

7. Market Value on Human Genetics Research:

The global market for Genetic Testing is forecast to reach US$2.2 billion by 2017. Increasing knowledge about the potential benefits in genetic testing is one of the prime reasons for the growth of the genetic testing market. Advancements in the genetic testing space, aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.

Visit link:

Genetics Conferences | Human Genetics Conferences | Europe ...